Page 4 - Geoff Porges News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Geoff porges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Geoff Porges Today - Breaking & Trending Today

Leerink Partners Remains a Hold on Radius Health (RDUS)


Markets
Leerink Partners analyst Geoff Porges maintained a Hold rating on Radius Health (RDUS – Research Report) on April 22. The company’s shares closed last Friday at $20.90.
According to TipRanks.com, Porges is a 3-star analyst with an average return of 5.9% and a 49.5% success rate. Porges covers the Healthcare sector, focusing on stocks such as Alexion Pharmaceuticals, Vertex Pharmaceuticals, and Theravance Biopharma.
Radius Health has an analyst consensus of Moderate Buy, with a price target consensus of $29.00.
Radius Health’s market cap is currently $980.1M and has a P/E ratio of -8.50. The company has a Price to Book ratio of -7.25. ....

Michael Rosenblatt , Stavrosc Manolagas , Theravance Biopharma , John Katzenellenbogen , Geoff Porges , Johnt Potts , Vertex Pharmaceuticals , Alexion Pharmaceuticals , Radius Health , Research Report On , Radius Health Inc , Leerink Partners , Research Report , Moderate Buy , மைக்கேல் ரோசன்ப்ளாட் , ஜியோஃப் போற்கேஸ் , வெர்டெக்ஸ் மருந்துகள் , அலெக்சியன் மருந்துகள் , ஆரம் ஆரோக்கியம் , ஆராய்ச்சி அறிக்கை ஆன் , ஆரம் ஆரோக்கியம் இன்க் , ஆராய்ச்சி அறிக்கை , மிதமான வாங்க ,

Sanofi (SNY) Q4 2020 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Sanofi Fourth Quarter 2020 Earnings Call and Virtual Capital Markets Day. We have planned for a 15-minute break between both events. You may remain connected to the Zoom link for all sessions.
I would now like to turn the call over to Eva Schaefer-Jansen, Head of Sanofi Investor Relations. Please go ahead, Eva.
Eva Schaefer-Jansen
Head of Investor Relations
Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi s 2020 fourth quarter results, followed by a dedicated Q&A session. In about an hour, we will begin our virtual Capital Markets Day presentation and discussion. As usual, you can find the slides to both sessions on the Investors page of our website at sanofi.com. ....

France General , United States , Societe Generale , Thomas Triomphe , Florent Cespedes , Sanofi Pasteur , Paul Hudson , Flubok Supemtek , Julie Van Ongevalle , Wimal Kapadia , Eva Schaefer Jansen , Olivier Charmeil , America Merrill Lynch , Pete Verdult , John Reed , Enregistrement Universel , Sanofi Genzyme , Peter Verdult Citigroup , Jo Walton , Richard Vosser , Geoff Porges , Wimal Kapadia Bernstein , Digestive Health , Global Head Of Research Development , Graham Parry Bank , Garnier Co Analyst ,